Puma Biotechnology (PBYI) EV to EBITDA (2021 - 2026)
Puma Biotechnology's (PBYI) EV to EBITDA came in at 7.83 for Q2 2026, up 498.1% from 1.31 a year earlier and up 40.9% from the prior quarter.
Powered by 
Analysis
Puma Biotechnology (PBYI) EV to EBITDA (2021 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EV to EBITDA at Puma Biotechnology was 0.66; for FY2025, it was 4.20, up 265.3% from FY2024.
- In prior years, Puma Biotechnology's EV to EBITDA was 1.15 in FY2024 (-54.0%), 2.50 in FY2023 (-27.0%), 3.43 in FY2022 (+0.2%) and 3.42 in FY2021.
- The Q2 2026 figure stands as the highest quarterly EV to EBITDA since Q1 2021.
- On a year-over-year basis, EV to EBITDA has increased in each of the last four quarters, with growth averaging 183.7% over the last eight quarters.
- The strongest year-over-year quarter for EV to EBITDA in the past five years was Q3 2025, with growth of 500.1%; the weakest was Q1 2025, with a decline of 72.1%.
- According to Business Quant data, EV to EBITDA for the three prior quarters was 5.56 (Q1 2026), 4.20 (Q4 2025) and 3.88 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Puma Biotechnology | 507.45 Mn | 120.09 Mn | 44.03 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.83 |
| Mar 31, 2026 | 5.56 |
| Dec 31, 2025 | 4.20 |
| Sep 30, 2025 | 3.88 |
| Jun 30, 2025 | 1.31 |
| Mar 31, 2025 | 1.10 |
| Dec 31, 2024 | 1.15 |
| Sep 30, 2024 | 0.65 |
| Jun 30, 2024 | 2.01 |
| Mar 31, 2024 | 3.96 |
| Dec 31, 2023 | 2.50 |
| Sep 30, 2023 | 1.03 |
| Jun 30, 2023 | 2.82 |
| Mar 31, 2023 | 1.87 |
| Dec 31, 2022 | 3.43 |
| Sep 30, 2022 | 0.98 |
| Jun 30, 2022 | 3.50 |
| Dec 31, 2021 | 3.39 |
| Mar 31, 2021 | 18.78 |
API Access
Puma Biotechnology EV to EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=PBYI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-ebitda", "ticker": "PBYI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=PBYI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();